Asahi shares mark weekly slide after cyberattack halts production
NEW YORK - Chimera Investment Corporation (NYSE:CIM) announced on Thursday that its Board of Directors has declared a third quarter cash dividend of $0.37 per common share. The company, which currently offers an attractive 10.58% dividend yield, has maintained consistent dividend payments for 19 consecutive years, according to InvestingPro data.
The dividend will be payable on October 31, 2025, to stockholders of record as of September 30, 2025, according to a company press release. The ex-dividend date is also set for September 30, 2025.
Chimera Investment Corporation operates as a real estate investment trust (REIT) that focuses on providing returns linked to mortgage credit fundamentals. The company invests in various mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, and mortgage servicing rights.
The company typically invests on a leveraged basis in diversified portfolios of mortgage-related assets. Chimera also engages in investment management and advisory services activities for its own account and on behalf of third-party clients.
This dividend announcement represents a regular quarterly distribution to shareholders as part of the company’s operations as a REIT, which requires distribution of a significant portion of taxable income to maintain its REIT status.
In other recent news, Chimera Investment Corporation announced its Q2 2025 earnings, which fell short of analysts’ expectations. The company reported an earnings per share (EPS) of $0.39, missing the forecasted $0.46, and revenue of $67.39 million, which was below the expected $81.6 million. Additionally, Chimera Investment Corporation has closed a $120 million senior notes offering with an 8.875% interest rate, including $5 million issued through an over-allotment option. The company plans to list these notes on the New York Stock Exchange under the symbol "CIMP." Prior to this, Chimera had priced an underwritten public offering of $115 million in senior notes at the same interest rate. This offering included a 30-day option for underwriters to purchase up to an additional $17.25 million in notes to cover over-allotments. These recent developments highlight Chimera’s financial activities and market interactions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.